Лечение дисменореи в амбулаторных условиях: современные возможности
Аннотация
Об авторах
О. В. КачалинаРоссия
д.м.н., доцент кафедры акушерства и гинекологии,
Нижний Новгород
А. А. Коренькова
Россия
аспирант кафедры акушерства и гинекологии,
Нижний Новгород
Список литературы
1. Унанян А.Л. и соавт. Современные представления об этиопатогенезе, клинике и терапии дисменореи. Медицинский совет, 2017, 2: 112- 115.
2. Серов В.Н., Прилепская В.Н., Овсянникова Т.В. Гинекологическая эндокринология. 4-е изд. М.: МЕДпресс-информ, 2012. 528 с.
3. Pitangui AC, Gomes MR, Lima AS, Schwingel PA,Albuquerque AP, de Araujo RC. Menstruation disturbances: prevalence, characteristics, and effects on the activities of daily living among adolescent girls from Brazil. J Pediatr Adolesc Gynecol, 2013, 26: 148–152.
4. Ayan M, Sogut E, Tas U, Erdemir F, Sahin M, Suren M, Kaya Z, Demirturk F. Pain levels associated with renal colic and primary dysmenorrhea: a prospective controlled study with objective and subjective outcomes. Arch Gynecol Obstet, 2012, 286: 403–409.
5. Banikarim C, Chaco MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med, 2000, 154: 1226-9.
6. Strinic T, Bukovic D, Pavelic L, Fajdic J, Herman I, Stipic I, et al. Anthropological and clinic characteristic in adolescent women with dysmenorrhea. Coll Antropol, 2003, 27: 707-11.
7. Унанян А.Л. и соавт. Дисменорея, аденомиоз, эндометриоз, опухолевый процесс: причинноследственные связи. 2017, 11: 186-188.
8. Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии. Под ред. В.Е. Радзинского, М.: ГЭОТАР-Медиа, 2014. 944 с.
9. Pejčić A, Janković S. Risk factors for dysmenorrhea among young adult female university students. Ann Ist Super Sanita, 2016 Jan-Mar, 52(1): 98-103.
10. Altunyurt S, Gol M, Altunyurt S, Sezer O, Demir N. Primary dysmenorrhea and uterine blood flow: a color Doppler study. J Reprod Med, 2005, 50: 251-5.
11. Lopez LM, Grimpes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Systematic Reviews, 2010, Issue 3, Art No.: CD003552.
12. Мозес В.Г., Ожогина Е.В. Первичная дисменорея, пособие для врачей, 2012.
13. Proctor ML, Roperts H, Farquar CM. Combinated oral contraceptive pill as treatment for primary dysmenorrhea. Cochrane Database of Systematic Reviews, 2001, 3: CD002120.
14. Клинические рекомендации. Акушерство и гинекология. Под ред. Г.М. Савельевой, В.Н. Серова, Г.Т. Сухих. 2009.
15. Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standart 21 day/7 day oral contraceptive ragimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynicol, 2002, 186: 1142-9.
16. Akerlund M, Forsling M, Kindahl H, Stimulator of vasopressin release in women with primary dysmenorrhea and after oral contraceptive tritment. Br J Obstet Gynicol, 1992, 99: 680-4.
17. Yusoff Dawood M. Primari Dismenorrhea. Advances in Pathogenesis and Management. ACOG, 2006 August, 108(2).
18. Wiegratz I, Kuhl H. Прием оральных контрацептивов в режиме длинного цикла. Drugs, 2004, 64: 2447-2462.
19. Ulmsten U. Uterine activity and blood flow in normal and dysmenorrheic women. Baltimore (MD), Urban and Schwarzenberg, 1985: 103-124.
20. Каратаев А.Е. и соавт. Клинические рекомендации: рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике. Современная ревматология, 2015, 9(1): 4-23. https://doi. org/10.14412/1996-7012-2015-1-4-23.
21. Dequeker J, Hawkey C, Kahan A. et al. Improvement in gastrointestinal tolerabilitiof the selective cyclooxygenase inhibitors, meloxicam, compared with peroxicam; results of the safety and efficacy largescale evaluation of COX-ihibiting therapies thrial in osteoarthritis. Br J Rheumatol, 1998, 37: 946-51.
22. Herel Z. A contemporary approach to dysmenorrhea in adolescents. Paediatr drugs, 2002, 4: 797-805.
23. Taha AS, Anderson VJ, Prasad R et al. Upper gastrointestinal bleeding and the changing use of COX-2 nonsteriodal anti-inflammatory drugs and low-dose aspirin. Aliment Pharmacol Ther, 2007, 26: 1171-8.
24. Gislason GH, Rasmussen JN, Abildstorm SZ. Increased Mortality and cardiovascular Mortality Associated With Use of nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure. Arch intern med, 2009, 169(2): 141-9.
25. Davis R, Brogden RN. Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs, 1994, 48: 431–54.
26. Rainsford KD. Mode of action, uses and sideeffects of anti-rheumatic drugs. In: Rainsford KD, ed. Advances in anti-rheumatic therapy. Boca Raton, FL: CRC Press, 1996: 59–111.
27. Воробьева О.В. Взаимосвязь спектра безопасности нимесулида и особенностей его механизма действия, химической структуры и фармакокинетики. Consilium Medicum, 2010, 2: 5–8.
28. Аlessandrini А, Ваllаriп Е, Ваstianon А, Мigliаvасса С. Clin Ther, 1986, 118(3): 177-82.
29. Transdermal glyceril trinitrate in the management of primary dysmenorrhea. Int J Ginaecol Obstet, 2000, 69: 113-8.
30. Wilson ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhea Coch rane Review. The Cochrane Library, 2001, Issue 3.
31. Ulmsten U. Calcium Dlocade as a rapid pharmacological to evaluate primary dysmenorrhea. Gynaecol Obstet invest, 1985, 20: 78-83.
32. Gokhale LB. Curative treatment of primary dysmenorrhea. Indian jornal of medical Research, 1996, 103: 227-231.
33. Ziaei S, Zakeri M, Kazemnejad A. A randomized controlled trial of vitamin E in the treatment of primary dysmenorrhea. BJOG, 2005, 112: 466-9.
34. Eccleston C, Williams. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews, 2009, Issue 2: CD007407.
35. Proctor ML, Hing W, Johnson TC. Spinal manipulation for primary and secondary dysmenorrhoea (Coch rane Review). The Cochrane Library, 2004, Issue 3.
36. Pallavi, Latthe. Factors predisposing women to chronic pelvic pain: systematic review. BMJ, 2006, 332: 749-755.
37. Pediatric and Adolescent Gynecology: EvidenceBased Clinical Practice (Endocrine Development, V. 7). Ed. Charles Sultan. Switzerland: S. KargerPub, 2004. 270 р.
38. Morrow C, Naumburg EH. Dysmenorrhea. Prim Care, 2009, 36(1): 19–32.
39. Стругацкий В.М., Маланова Т.Б., Арсланян К.Н. Физиотерапия в практике акушера-гинеколога: Клинические аспекты и рецептура. М.: МЕДпресс-информ, 2008. 272 с.
40. Proctor ML, Smith CA. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhea. In: The Cochrane Librari, Issule 1, 2002. Oxford: update Software.
41. Qu F, Zhou J, Ma B. The effect of chinese herbs on the cytokines of rats with endometriosis. J Altern Complement Med, 2005, 11: 627-630.
42. Yu S, Yang J, Yang M, Gao Y, Chen J, Ren Y, Zhang L, Chen L, Liang F, Hu Y. Application of acuoints and meridians for the treatment of primary dysmenorrhea: a data mining-based literature study. Evid Based Complement Alternat Med, 2015: 752194.
43. Ortiz MI, Cortés-Márquez SK, Romero-Quezada LC, Murguía-Cánovas G, Jaramillo Díaz AP. Effect of a physiotherapy program in women with primary dysmenorrhea. Eur J Obstet Gynecol Reprod Biol, 2015 Nov, 194: 24-9.
Рецензия
Для цитирования:
Качалина О.В., Коренькова А.А. Лечение дисменореи в амбулаторных условиях: современные возможности. Медицинский Совет. 2018;(13):174-178. https://doi.org/10.21518/2079-701X-2018-13-174-178
For citation:
Kachalina O.V., Korenkova A.A. Management of dismenorea in outpatient settings: modern opportunities. Meditsinskiy sovet = Medical Council. 2018;(13):174-178. (In Russ.) https://doi.org/10.21518/2079-701X-2018-13-174-178